Allison Luo
Chief Tech/Sci/R&D Officer at PROMETHEUS BIOSCIENCES, INC.
Allison Luo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/08/2018 | - |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2017 | - |
Career history of Allison Luo
Former positions of Allison Luo
| Companies | Position | Start | End |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 01/09/2006 | 01/10/2014 |
| IVERIC BIO, INC. | Corporate Officer/Principal | 01/09/2015 | - |
| ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - | - |
Training of Allison Luo
| Northwestern University | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Private companies | 2 |
|---|---|
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Allison Luo
- Experience
